Clinical Trial

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-03-21; most recent amendment 2025-06-01.
Status change: Completed → Recruiting 2023-02-01
Status change: Recruiting → Completed 2021-04-27
Trial Details
NCT Number NCT04320199
Lead Sponsor Pusan National University Yangsan Hospital
Conditions Alcoholic Liver Disease
Enrollment 30 participants
Start Date 2020-01-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-04